GLS and HIV-1 infection: The protein levels of GAC, a GLS1 isoform previously identified to have neurotoxic potential, were also increased in MVs after HIV-1 infection and diminished after GW4869 treatment, indicating that MVs carried GAC as cargo and that HIV-1 increases GAC release through MVs (Fig. 2a, d).